590 filings
Page 7 of 30
8-K
a8otsvnx70er7ykzxcu
14 Jun 21
9 Meters Announces Initiation of Phase 2 VIBRANT Study of Vurolenatide for Short Bowel Syndrome
7:32am
8-K
sjh6c8j
26 May 21
9 Meters Biopharma, Inc. Announces Publication in Journal of Clinical Investigation Describing Successful Use of Larazotide for Treating
8:33am
8-K
ntkod2cwji7y21dw8
17 May 21
Other Events
7:36am
4
t491gec
13 May 21
Change in insider ownership
6:34pm
8-K
476 8k03n1
13 May 21
9 Meters Biopharma Provides Business Update and Reports Financial Results for the First Quarter 2021
7:47am
DEFA14A
3il1y8c
12 May 21
Additional proxy soliciting materials
7:32am
8-K
sl8xsuk52jy783br07k
21 Apr 21
9 Meters Biopharma, Inc. to Participate in the Truist Securities
7:33am
8-K
7179g2 hyj2s
19 Apr 21
9 Meters Biopharma, Inc. Announces Collaboration with the Duke Clinical Research Institute to Support 9 Meters’ Program in Short Bowel Syndrome
7:32am
8-K
b4hkt
12 Apr 21
9 Meters Biopharma, Inc. and Celiac Disease Foundation Announce Collaboration to Support Clinical Trial Enrollment in 9 Meters’ Phase 3 CeDLara Study
7:32am
SC 13D/A
xw1px0ve
7 Apr 21
9 METERS BIOPHARMA / OrbiMed Israel BioFund GP Limited Partnership ownership change
4:46pm
4
qj3sytp4fwil5by
6 Apr 21
9 METERS BIOPHARMA / Mark A Sirgo ownership change
4:19pm
4
q9r1983x
6 Apr 21
9 METERS BIOPHARMA / John Temperato ownership change
4:16pm
4
w2o8v5xdvtkb
6 Apr 21
9 METERS BIOPHARMA / Edward J Sitar ownership change
4:15pm
8-K
er8g302ar69ukq 5nq
5 Apr 21
9 Meters Biopharma Announces Proposed Public Offering of Common Stock
4:26pm
424B5
9nxe2
31 Mar 21
Prospectus supplement for primary offering
4:40pm
424B5
vnhqrzqyhw pgxr
30 Mar 21
Prospectus supplement for primary offering
5:01pm
SC 13D/A
2z45v1x8v11jpxk
25 Mar 21
9 METERS BIOPHARMA / OrbiMed Israel BioFund GP Limited Partnership ownership change
12:00am